Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2023
Filter by date:
Showing 1262 press releases before 2023
-
European regulator backs nasal spray vaccine FLUENZ for the prevention of seasonal influenza in children
-
Positive agreement received for approval of VIMOVO in Europe
-
New outcomes study for ticagrelor (BRILINTA™) to examine longer-term treatment for post- ACS patients
-
AstraZeneca initiates phase III clinical development of fostamatinib for the treatment of rheumatoid arthritis
-
Results of Zibotentan Phase III trial in castration resistant prostate cancer
-
52-Week Phase 3 Study Found Investigational Drug Dapagliflozin Plus Metformin Similar to Glipizide Plus Metformin in Improving Glycosylated Hemoglobin (HbA1c) in Adults with Type 2 Diabetes Mellitus
-
BRILIQUE (ticagrelor) receives positive opinion from European CHMP for the treatment of Acute Coronary Syndromes
-
US and EU regulatory submissions for VANDETANIB in advanced medullary thyroid cancer accepted for review
-
24-Week Phase 3 Study Found Investigational Drug Dapagliflozin Improved Glycosylated Hemoglobin (HbA1c) When Added to Glimepiride in Adults with Type 2 Diabetes Mellitus
-
US Food and Drug Administration Extends Review Timeline For BRILINTA (Ticagrelor) New Drug Application
Latest articles and press releases
All of our latest press releases and articles are available to explore
Use a maximum of two downloads here